• Mashup Score: 0

    Ayman Askari, MD, discusses the recent trends in rheumatoid arthritis, studies presented at the American College of Rheumatology (ACR) Convergence 2022, and the pressing issues that face rheumatologists moving into 2023.

    Tweet Tweets with this article
    • Will comparisons between Janus kinase (JAK) inhibitors be more thoroughly researched in the upcoming year? Read our interview with Ayman Askari, MD, below: https://t.co/5mxuEVDmvV #RheumatoidArthritis #Rheumatology

  • Mashup Score: 0

    Despite gout being largely associated with White men, new data suggest gout and hyperuricemia impart a larger burden on other demographic groups, including Black men, Black women, and White women.

    Tweet Tweets with this article
    • A nationally representative race- and sex-specific study of adult patients in the United States reported that #gout was more prevalent in those self-reporting Black race when compared with White participants. https://t.co/MOhYxvk7WG

  • Mashup Score: 0

    Alfredo Aguirre, MD, discusses the latest data regarding lupus this year at the American College of Rheumatology (ACR) Convergence 2022, trends in lupus management, and the importance of remission in lupus.

    Tweet Tweets with this article
    • Alfredo Aguirre, MD, discusses the latest data regarding #lupus this year at the American College of #Rheumatology (ACR) Convergence 2022, trends in lupus management, and the importance of remission in lupus. https://t.co/mcxHnCJTAR https://t.co/mM8UlHnBMz